SMS Lifesciences India Balance Sheet Health
Financial Health criteria checks 4/6
SMS Lifesciences India has a total shareholder equity of ₹2.0B and total debt of ₹894.9M, which brings its debt-to-equity ratio to 44%. Its total assets and total liabilities are ₹3.9B and ₹1.9B respectively. SMS Lifesciences India's EBIT is ₹307.4M making its interest coverage ratio 3.3. It has cash and short-term investments of ₹11.9M.
Key information
44.0%
Debt to equity ratio
₹894.94m
Debt
| Interest coverage ratio | 3.3x |
| Cash | ₹11.92m |
| Equity | ₹2.03b |
| Total liabilities | ₹1.88b |
| Total assets | ₹3.91b |
Recent financial health updates
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Recent updates
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive
Nov 14Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Financial Position Analysis
Short Term Liabilities: SMSLIFE's short term assets (₹1.5B) exceed its short term liabilities (₹1.4B).
Long Term Liabilities: SMSLIFE's short term assets (₹1.5B) exceed its long term liabilities (₹441.0M).
Debt to Equity History and Analysis
Debt Level: SMSLIFE's net debt to equity ratio (43.4%) is considered high.
Reducing Debt: SMSLIFE's debt to equity ratio has increased from 42% to 44% over the past 5 years.
Debt Coverage: SMSLIFE's debt is well covered by operating cash flow (37.4%).
Interest Coverage: SMSLIFE's interest payments on its debt are well covered by EBIT (3.3x coverage).